Celgene Investors: Watch This Hearing In 5 Weeks
March 31, 2015 at 12:12 PM EDT
Citi issued a note on Celgene Corporation (NASDAQ: CELG) Tuesday ahead of a May 7 hearing to determine if the Revlimid EU polymorph ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.